Has Anubodh Varshney, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,996 in general payments to Anubodh Varshney, MD across 14 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Anubodh Varshney, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Anubodh Varshney, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Anubodh Varshney, MD

Advanced Heart Failure and Transplant Cardiology · Stanford, CANPI 1154734515

Payments from drug & device makers

What this record shows

The money is spread across several categories — travel and lodging (53.4%), food and beverage and education — rather than concentrated in one kind of arrangement. Cvrx, Inc. accounts for 79.1% of it on its own, with 4 other manufacturers making up the rest. 2025 is the largest year on record at $1,222, 5.2 times the $233 reported in 2022. That places this record below the midpoint for advanced heart failure and transplant cardiology clinicians in CA, where the typical reported total is $9,367.

$1,996in general payments, 2019–2025

Across 14 payments — averaging $142.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Cvrx, Inc.$2K
Abbott$305
Abiomed$47
Medtronic$40
Biotissue Holdings Inc.$25

What the payments were for

Travel & lodging$1,06653%
Food & beverage$69735%
Education$23312%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Cvrx, Inc.	8	$1,579
Abbott	2	$305
Abiomed	1	$47
Medtronic	2	$40
Biotissue Holdings Inc.	1	$25

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Barostim Neo System$1,491
QUADRA ASSURA$233

How this compares

$1,996 in reported general payments places this provider in the 25th percentile of 111 advanced heart failure and transplant cardiology providers in California.

See all advanced heart failure and transplant cardiology providers in California →

Medicare billing

Part B allowed, 2024

$142,963

Medicare patients

349

Services billed

1,063

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EntrestoSacubitril/Valsartan	54	$82,114
JardianceEmpagliflozin	51	$68,842
EliquisApixaban	27	$27,431
FarxigaDapagliflozin Propanediol	20	$26,139
Sirolimus	23	$13,061
Tacrolimus	69	$5,716
Mycophenolate Mofetil	18	$2,875
Cyclosporine ModifiedCyclosporine, Modified	13	$1,175
Bumetanide	18	$935
Metoprolol Succinate	58	$836
Rosuvastatin Calcium	87	$705
Spironolactone	81	$560
Carvedilol	79	$498
Losartan Potassium	64	$436
Valsartan	12	$422

Paid to pharmacies, not to this prescriber.

Other advanced heart failure and transplant cardiology in Stanford

Ronald WittelesStanford$251K
Jeffrey TeutebergStanford$195K
Kevin AlexanderStanford$125K
Eldrin LewisStanford$57K
Francois HaddadStanford$23K
Kiran KhushStanford$15K
Stephanie HsiaoStanford$12K
Richard WrightSanta Monica$1.7M
James Heywoodla Jolla$1.2M
Hirsch MehtaSan Diego$494K

See the full list for California →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →